Screener
Aura Biosciences, Inc. AURA Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Aura Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The source filing: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-216808
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Commitments and Contingencies (Note 12) | ||
| Stockholders’ Equity: | ||
| Common stock, $0.00001 par value, 150,000,000 authorized at March 31, 2026 and December 31, 2025, and 64,150,468 and 63,587,777 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | — | — |
| Additional paid-in capital | 621,557 | 617,433 |
| Accumulated deficit | (514,103) | (480,418) |
| Accumulated other comprehensive loss | (207) | (102) |
| Total Stockholders’ Equity | 107,247 | 136,913 |
| Total Liabilities and Stockholders’ Equity | $137,677 | $169,430 |
Item 1. Financial Statements.
FAQ
- What is Aura Biosciences, Inc.'s retained earnings?
- Aura Biosciences, Inc. (AURA) reported retained earnings of -$514.1M in Q1 2026.
- How has Aura Biosciences, Inc.'s retained earnings changed year-over-year?
- Aura Biosciences, Inc.'s retained earnings decreased by 28.0% year-over-year, from -$401.71M to -$514.1M.
- What is the long-term trend for Aura Biosciences, Inc.'s retained earnings?
- Over 5 years (2020 to 2025), Aura Biosciences, Inc.'s retained earnings has grown at a 32.7% compound annual growth rate (CAGR), from -$116.89M to -$480.42M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.
Ask your AI about Aura Biosciences, Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude